UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:December 23,
Lexaria Bioscience (NASDAQ:LEXX)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Lexaria Bioscience Charts.
Lexaria Bioscience (NASDAQ:LEXX)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Lexaria Bioscience Charts.

Lexaria Bioscience Corp. News

Form 8-K - Current report
Wednesday 17 July 2024 (1 week ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 12 July 2024 (2 weeks ago) • Edgar (US Regulatory)
Form DEF 14A - Other definitive proxy statements
Wednesday 6 March 2024 (5 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 1 March 2024 (5 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 16 February 2024 (5 months ago) • Edgar (US Regulatory)
Form D - Notice of Exempt Offering of Securities
Friday 16 February 2024 (5 months ago) • Edgar (US Regulatory)
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Wednesday 14 February 2024 (5 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (5 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 30 January 2024 (6 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 24 January 2024 (6 months ago) • Edgar (US Regulatory)
Form POS AM - Post-Effective amendments for registration statement
Wednesday 24 January 2024 (6 months ago) • Edgar (US Regulatory)
Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 18 January 2024 (6 months ago) • Edgar (US Regulatory)

More Lexaria Bioscience Corp. News Articles